Earnings call transcript Q3 2022

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Greetings, and welcome to Akili's Third Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions].

As a reminder, this conference is being recorded. to call like Young. to now would turn over the Joshua I you. Thank

You may begin.

Joshua Young

Good to name and call you, President afternoon, Thank Darryl. for Relations welcome and the third Akili. of of Investor Young, for quarter Akili's XXXX. Joshua My is I'm Vice the conference earnings

Officer; Shanbhag, on Officer Chief today's Executive for Eddie Operating Chief Akili. Martucci, are me Franklin, Officer; Financial With Chief call Matt and Santosh

issued section After on our our closed the we earnings accessed Relations today, can the which Investor of release, website. be market

Additionally, posted that slides call our we at a will at will recorded, website conclusion This IR teleconference replay the being we webcast. be of earnings have our event. IR available of the reference website during is on and today's today's

we our show statements. X, forward-looking On Slide

forward-looking assumptions call, statements regarding reasonable while prospects the we expectations, plans, performance make and the forward-looking by company. and company's These involve today's estimates events, that, will or upon certain future financial risks of management, uncertainties. considered the based statements are During

The those set to, Form any XX expressed are factors. filed differences limited differ but SEC. that result and a risks well might as or materially our other various Factors of include, from company's statements with as as by cause the forward-looking not implied forth those August may in filings those uncertainties actual results X-K important on subsequent

forward-looking reflects our of be disclaim or today's views as November statements any any only call explicitly date. on our as our subsequent outlook. We to upon any relied not Information representative or update views and other provided should revise of today, obligation of XX, as

measures to intend our does these financial as non-GAAP slides. earnings presentation but included non-GAAP is today's and provide substitute in isolation financial prepared our call, during the reconciliation A we Also in of GAAP, considered greater of certain refer earnings results non-GAAP release in to for the be a or financial is Management measures. in not will to complement our transparency. to a financial GAAP with accordance measures measures

like and turn please his would to to I X, Eddie -- that, turn to Slide Eddie? go remarks. like With prepared to the call for over I'd

Walter Martucci

Hi, Josh. company. as earnings for call Thanks first our joining public Thanks, everyone. a much so

As you a establish QX. this we're toward nervous or new looking medicine. at of progress and third think on Akili, going meaningful we're In here into to know, to we excited that momentum central class the build quarter, I system, made vision CNS,

building to for debate opportunity If for moment you market turn want mental to simply, think don't and we targeted and need medicine on better the treatments. I that precisely X, into. we're a get patients believe up specific need health. more patient that's Very need Slide the We I behavioral anymore. for

cognitive our with a can information, across areas improve one disease Specifically, in treatments we see functioning. now cognitive opportunities largest ability term. impairment the of more that more attention is discussed many pay focus of It's X Such to directly things to like focus. is for that and being more to process medicine,

friendships, day-to-day their of important. is impairments quality school, can this impact It's children, For life. Cognitive their critical. really

cognitive of we're unfortunately has Slide access X few issues. known like conditions decades. pharmaceuticals There's well remained you also neither families behavioral the know that and for crisis X, it's options essentially afford to turn these behavioral in specifically health treating Unfortunately, very of and If therapy. mental actually midst growing ADHD and therapy can we same a or the options, target

and especially society about most these the left for concern means today is overuse really they're in is growing there's a of a option, that families, single potential with And pharmaceuticals, we what which effects pharmaceuticals. that So know children. across

fear. of new their and to and the a alongside patients are that brain believe We and therapy, safe, physiology medication to and treatment treatments are the need. believe accessible options represent looking have digital positioning pillar treatment establish. instead we're targeting bring they that and effective, That's the for that's want joy new we the that to possibility believe ready are providers and So we

and broadening ADHD from then there. in First

this If we've journals. and you turn built to peer-reviewed Slide is validated in X, published what clinically

And delivered neural and feels underlying enjoyable the cognitive software it's through a platform intervention, behavioral Our that a plays strategy it a SSME case, networks designed functioning. in technology and like to It's targeted represents we call be this intervention, or is behavioral target functioning, directly behavioral because this video therapy. game. next-generation it tension and software it a but looks not can a

we're If you first platform Slide EndeavorRx. this of out at product X, our look very of proud

other As you treatment program that functioning resources. in can the with children, improve of is or FDA by a all that's be attention part meant know, combined-type XX to ADHD. education used medication to a or or indicated to product behavioral X This as therapy it's or inattentive authorized include

flexible So medicine can be aspects is of pillar of other and it with new that that medicine. is used

excited currently small EndeavorRx at being We're prescribed across country. the that is scale

the business of routine To medical point And clear, care we very be treatments is in at ADHD driving a have the for like that's mainstream pharmaceuticals. our software-based efficient to now, at so become bold and right focus our of in on Akili, pretty market. time, part goal this growth

we into. with believe that and date, approach but product with market specific it's haven't seen the our we're possible with We to the digital going

end, on are that To uptake leading uptake mainstream team focused of you're this EndeavorRx. hear metrics of we breadth the that today -- believe of to primarily of indicators going

over date, XX states. For example, to from we've today excited that written we're prescriptions who we've prescriptions. seen seen have X,XXX doctors all Similarly

we potential it's and early think growth, shows looking to consistent of see good quarter-over-quarter breadth. now, indicators are foundation our a that But that's focus. we right So

the also lives. sense patients playing of Slide can motivating. incredibly believe families medicine. and CNS you now role children's a the that scale, some see X, their to us in I that shared that and pretty EndeavorRx of on the from quotes interesting some What's families rare of you empowerment If families we slide. in is really important move put at here is we're hearing in in And from see increase that is to with children the is And these have testimonials

we're here. category a and focus on focus, to and new we internal It model. realize an execution extreme then takes iteration creating nail and have We our grow

us for planned Our plan with I'm current to until a operations technologies, we're President and care we we Franklin, and and excited business growth, sufficient models believe delivering profitable COO, Matt mid-XXXX. that a capital have career this our joined launching what business. live is summer health aiming and as that's now and innovative our go-to-market establishing of fund new

progress. turn going to over pass business Slide talk now I'm to and you the if X, strategy our So call our business through to go-to-market to and Matt

Matthew Franklin

Eddie. All right. Thank you,

see launch with looks of The we're like of you time. quarter moved establishing critical kids you to to pillars point already transition that us. to starting commercial for EndeavorRx, marked foundational to and clinical over as EndeavorRx through also achieving impact. the that how the plan are third our I'll We part prelaunch scale from I'll care significant through of take ADHD. our routine we walk goal of and for what first launch a an activities phase

anyone the us EndeavorRx is benefit products that and any that course, be a flexible, last over we've picturing working. a simple, to initiate months, to fulfillment infrastructure. allowing ideally evolve prerequisite the built, launch XX it's written. having treatment is Slide And built scalable infrastructure designed here Of is can We're time. and for from XX infrastructure of enable data prescription or able to over customer now is a future commercial to our quickly, same This on

If you Slide XX, I'm turn this while going to on spend slide. to a

Our walk these through strategy key go-to-market areas, on coverage and each I'll of adoption, areas: in is progress experience. core I'll strategy metrics. X focused first our on share you and

look let's adoption. First, at

the initial of Our to us volume direct XXXX. engage now in market care health XX prescriptions. in this on and key strategy opportunity and focused prioritized force clinicians we is engaging our provider to brought on providers field. sales sales frequent been QX We with trained, a of launch, they're to interaction. by phase commercial In territories with bounding enables that the by with They've of reps maintain board late geography increase

a of providers have reps integrated territories are representation. liaisons expanding where reps and yet also do direct sales focused on have medical supported by that an up small marketing not inside originate sales we on team field in we The care prescriptions science health follow to strategy with and Additionally, our awareness caregivers.

the centers pediatric and pediatricians tend ADHD. reps providers, targeting complex ongoing are treat management to primary groups quickly, pediatricians. centers proportion multidisciplinary behavioral more responsible approaches Our health are adopt Behavioral that practices a health of patients with of innovative of cases X treatment while the ADHD majority of high and for integrated are

insights, these to and next this quickly is wave, scale. footprint approach enable measuring capabilities refining first engage, progress build and months. will best are practices our we XX efficiently Eddie As and over that believe then the national shared, out to our capturing us iterate In learn, we

change of pocket, the Now thousands including let's committed see vast EndeavorRx needs To date, EndeavorRx Of to in disparity area current clinical the patients. disorders, paid access and and out families of of part all at routine to look to focus, be a prescriptions our become care, coverage. to second accessible written the treating we're to ADHD. of socioeconomic have reduce mental driving to health majority of we improve

coverage commercial PBMs, for state Medicaid to is to engage strategy insurers EndeavorRx. Our plans establish national and with

have than third therapeutics. Blue from for in now digital seeing the signals Blue of million the market these it's with and Cross positive prescription X stakeholders efforts. access members early, In We these quarter, more Highmark, each medical included on we focused EndeavorRx largest fourth team their organization are policy Shield while the

may follow We footsteps. expect like their to Highmark others in influence leaders

through also while for patient coverage program coverage. the EndeavorRx, for Therapeutics important that that a those enable commercial prescription offer we provide these provide paying covering and families Act of note called Pam's It's to for assistance and Prescription Digital and the discounted a therapeutic are Medicaid working digital to we addition, Medicare out for qualify prescription In insurance industry legislation Access a pocket. a wait to with catalyst

motivate focus engaged adapt and be product experience. we engagement as third meet time. to therapeutics delivered drive to many evolving Features because our capture over levers treatment is have compliance. on engaging treatment creature game the format, video can is game pediatric within to EndeavorRx our Finally, Unlike and can modified with digital patients through character patient the pharmaceuticals, to stay And such the area costumes and needs. of enhance quest, an

their Roblox to child's allows products of not and overall support team phases. mobile encourage just services, with to data by of treatment to partnership our completion And families mechanism caregivers insights a in plan. deliver patients the At but gaming our us to great treatment us also enhance entrusted reward is example using the continually Akili, our enables to

data These creating allow meaningful team. care to put us their child's families relationships to ongoing and with with towards caregivers have work discussions

example, Insight that well in-game the Insights, level completion putting child's of their of to of we treatment. as caregivers treatment. families the and effort to as EndeavorRx that get the For allows companion recently a EndeavorRx child's daily connects EndeavorRx snapshot mission see introduced into progress they're

We Xx that actively more found course Insight, complete likely to uses of is caregiver the child if have XX-day their EndeavorRx treatment. full their

We continue to from to plan feedback. based feedback the on families EndeavorRx refine this source and

zoom out to metrics at and EndeavorRx let's date. Now look

Moving to Slide XX.

third was the are behaviors prescriber report prescription strong performance show that volume, that we're of leading our the in the as indicators EndeavorRx: categories areas to I'm reimbursement. and of in pleased at traction XXXX. Here all caregiver and quarter X looking

As of third was quarter. force end a until sales the the of the live majority not reminder, our

total increase X,XXX, XX% is prior of prescriptions than written quarter. versus the in third was The XXXX more of which number quarter

third versus the the the New of the XXXX. in prescriptions total in represented prescriptions prior XX% launch. of quarter this We're growth initial encouraged more commercial quarter refills also in than written by of phase XX%

prescribing we EndeavorRx. mentioned, than in the Eddie front, had with first in universe To XX versus greater the continue states. On prescribers prescription as who prescribers number of growth quarter XX% the the prescriber date, for quarter, to all third and the second we've their expand wrote

of that is laying month first-ever every prescriptions XXX we're providers every game XXX thing multiple in write adding prescribers new more but small we're than month. treatment a That's One for for a consistently patients. about excited number particularly prescribers growing video prescription their

indication in continued third that From quarter greater a we in pocket to to view in new value dispensed an prescription caregiver pay which written from was be to it of as XX% treatment. quarter are perspective, the and the second XXXX, see than willing EndeavorRx the conversion out of for parents as

prescription. our Looking for at pricing, $XXX price list a is XX-day

a cost $XXX, was that the we shift for of discounted year, was of price second the the the which went quarter, $XX prescription. out-of-pocket at course program, in dispensed to XX-day they assistance through were $XXX a quarter of Note the a prescriptions XX-day by current patient paid with cost patient. offer price to during our a means prescriptions Our third Overall, cost. were selling $XX the prescription in provided average excluding third our of the similar no program, patients XX-day which the did prescription to as from XX% self-paid assistance we the patient with quarter. us out-of-pocket X%

In the by terms of insurance third X% prescriptions reimbursement reimbursed of in about quarter, companies. were EndeavorRx

large that source no which being as editions no we due lives the of longer believe may percent basis. report ongoing With lives confirmed are You their reliable fluctuates as and plan do we each we well metric covered longer to quarter. accuracy on a frequently, an of covered to notice reimbursed ability Highmark to with that reporting covered like issues is data, report also said, prescriptions

our up EndeavorRx the we're wraps work doing of That launch. discussions on

Turning Slide to our now pipeline pictured XX. on

to Our from and this the XX us a next platform over address should what months. expect markets, see potential capability sense provides multiple has of you the to

and our Given is on focused be keep commercialization to resources our goal capital our label desire efficient, expansion. EndeavorRx to ADHD

ADHD, Beyond clinical for do to work keep ready our the pipeline only activation. needed programs we'll

we into funds are development of next allocate clear, of be the currently beyond To outside these planning to phase programs not milestones. to clinical stated progress the ADHD

prelaunch the to EndeavorRx. of first shared, I this the launch transition with milestone As from the completed on chart we

We multiple initial pediatric market beyond our future also label. U.S. have opportunities

by in do One huge We EU, is trial expansion. In Japan, Japan our commercialization. the current that pivotal in in ADHD end and received market is XXXX. have launch actively progressing in the for we clinical do Shionogi, year. opportunity have track plans CE a work not geographic that to readout of Shionogi partner, on a third towards next the quarter, but trial initiated Mark is an we data

future age market opportunity range U.S. label is Another ADHD in expansion the

here. We programs X have

and out First, a next expected to track by pivotal trial in on year. of adolescents is the end read

to anticipated. actively or Second, patients, is may trial trial pivotal readout is our slower for adults to line progressing need be adjustments the currently that achieving to but We're evaluating enrolling in milestone. made the than data time the

previously the X- of XXXX Third, we are partnering old. the X-year with stated first ADHD in in TALi to Health expected on the study. half We for pilot program start

leadership. However, undergone confirm this this for And are at as new timing a discussions TALi this has ongoing, in our leadership with study the in time. group change we team to age not start able a

We updated will soon provide possible. an time as as line

expansion already XX. where final conditions I'm happy with autism we held And October clinical is in FDA in beyond chronic in platform product area that we Q-Sub our confirm data. for have ADHD The meeting to

We multiple are major also in for our on Q-Sub meeting depressive disorder. track FDA milestones sclerosis and

be end expect read of this by of studies to line of slated the And COVID. in we are of was our year, studies delayed one end study research at top technology from the second is this out while data least X by at the there year. by a conducted Lastly, institutions quarter. outside Data academic being the

We next choice from line analyze these able both together of and have year. top the first to the data made in expect to trials half studies share to data the from be

for the financial Santosh call to I'll now the turn over update. Santosh?

Santosh Shanbhag

and Matt, hello, everyone. you, Thank

to just to us believe clinical are excited product, progress people the the States. ADHD us gives potential We United X.X million the Matt up remind near-term everyone, really walked with expand about marketed that to plus our we programs To in through.

around public achieve we we United filings, shots to per revenue ADHD multiple reimbursement and goal refill to X generating within X With long-term of in market years. and next and penetration, prior million behavior the the the year assumptions objective least have our pricing at in States shared our had conservative $XXX in of

of Slide in Note capital the to our payments the in the with of this XX, spend $XX,XXX year. and in compared included and will We third last collaboration. position. I $XX,XXX our associated revenue $XX,XXX see quarter of year GAAP of year few from milestone third On generated quarter the financial that quarter third the financials revenue our last in $XXX,XXX QX minutes talking the next second quarter Shionogi performance. you can about

the a $XX income We in quarter of GAAP are reporting net million third approximately XXXX. of

price. to million $XX noncash a Our the GAAP the financials the P&L. mark-to-market share the we accounting were a the approach, positively Akili's by affected recorded associated leaseback earn-out related earn-out lower significantly is with in process. gain due on based of Reliability shares these approximately on was liability shares Since to pullback a

liability. to non-GAAP shares key This to the non-GAAP of represents adjusted Turning run financial at Slide measures earn-out to uses in that transaction allocated the quarter. end value financial exclude slide for figures market mark-to-market costs of adjusted stock-based well the change to release as in These fair A management show non-GAAP the metrics share business. provided the directly and as our our the GAAP earn-out earnings is We compensation, XX. the performance measures the comparable reconciliation presentation. of

In this the the XX% in year. the EndeavorRx. third incurred marketing timing of to This quarter the discretionary million quarter decrease launch of expenses, of of operating decrease to $XX.X a to of due compared expenses primarily was related non-GAAP second we year, the

building expect We phase are we QX initial out and marketing sales of our acceleration launch, the an commercial our are discretionary spend in the of force. that in now we

of includes from short-term $XXX.X combination. We net received quarter business in This perspective. $XXX.X and the with ended proceeds million a the we cash, From million investments. capital cash equivalents

focus of this and capital-efficient our believe of sufficient resources the and ADHD to label to fund current we and mentioned, commercialization as planned have mid-XXXX. Matt we plan, on operations cash majority the until With Now that EndeavorRx our is goal expansion. keep vast on

With over hand that, so Josh back can I'll your questions. we to it take

Joshua Young

Darryl, you assemble Thank much. the very roster. please Q&A

Operator

[Operator Instructions].

line Cowen. Charles with coming is first Our question Rhyee from of the

Charles Rhyee

the everyone, coverage. a on I Highmark coverage first Can know you thoughts the far your little obviously, in quarter on more so covered you is Congratulations, -- Is Yes. And gaining a is terms with you lives Endeavor's about us And detail are formulary? Is who se, things Medicaid more all to available bit their insured? this members? to fully where more decision Or I then talk interested really give on but that here. ASO bit don't it it about per that about mean to want there? if so, agencies? where Eddie, little is does it state available your want talk to? of interesting. stand

Walter Martucci

Charles. Sure, the Thanks question. for

view do for moment this EndeavorRx category. as I Akili an Highmark, So for breadth of important and broader

in get So your question. specific on to more that

medically So Highmark policy, which doctor therapeutics, label is including policy, did necessary. on considered create digital prescribed is medical when which by that prescription is that a EndeavorRx a policy, on

And very the policy, off so no is prior that label. a crop essentially or prior clean offs

And this that's so about if you think important payer it's the patients, will, but question to both I momentum, also time, framework access because creating broader world. at it's your to because really point a giving in in the

We seeing is to that there simple and put to is existed given create more engagement. policy category how for to out are that this get hasn't there deeper gives discussions. We're more logistically payers. access policies, how a engagement seeing do from payer into patients. on But a think groups I hesitation before, seeing is that We're continued EndeavorRx,

world I say of certainly, that a for blueprint that, that I'm influence and roadmap can't exactly others. And type play or in press. got others. policy much decision a the that gives lot it the in Highmark laser is and how hopeful the blueprint. press think I So that But of public will

a a and Medicaid, where good In have That question. We of ours. state focus is terms there focus with discussions is a it's of team do Medicaid.

any us. announced contracts Medicaid, yet not an have but is this of focus for with We area

of we on. it's important is continue on area Medicaid And so And X/X do go to will focus ADHD lives we XXXX, we fall that into at where do anticipate, for pediatrics. as about that least in this an

over and hope some us, level a work wins continue we focus for that to there. of certainly and So turn

Charles Rhyee

could would covered think the... on really under do that benefit. that follow If up the That's is Highmark That pharmacy just decision. helpful. And not and I Endeavor you is benefit indicate the the medical that,

Walter Martucci

right. That's

Charles Rhyee

pharmacy for Is have a with prescription? it you a team that do of think regular make Or way forward, to lot had the more of plans? path you health discussions the

Walter Martucci

a It's good question, Yes. Charles.

look to I think medical. what too term of like, where will EndeavorRx, for in early tell versus it's terms -- long the pharmacy distribution

We continuing and have done are the for to to both enable work EndeavorRx. work

about And given being class. a it's so important flexibility we've pretty been public new

Highmark you're policy. so was right, medical And

to our on opinion, I put interest do to think, whereas path. discussion Highmark policy. expect others and this as shown a from payer path there medical -- that viable is pretty this would there I it is payers, both. a But my has depends the on that with is clear in see

be distribution, of So in I tell. too terms a but think think will look will early to there distribution exactly I like, that what

Charles Rhyee

the just policy last, why they put just to the benefit medical chose in. maybe they under And squeeze pharmacy? Did indicate versus medical

Walter Martucci

Highmark No. information for don't have. about They've decision but I level can't their public of speak processes, some think been And no, I of a we that that's there.

Operator

line with Suisse. Our next from Frommer is question coming Judah of the Credit

Judah Frommer

progress the on here. Congrats

kind the effort. sales force of out wanted couple marketing questions on with of and Just initial a start to

nationally really So physicians. more folks those And opposed targeted marketing are, on by territories. their maybe non-pharmacological being is decision sound with caregivers the It focused a to to driven the of coming to caregivers? give target as like done here. to relatively can you guess if just effort spend time deeper going does What's are seems us is you're going, the the sales territories and it within us like going largely then broad sales an to what from go short expand relatively I where in frame, backgrounds idea

Matthew Franklin

I'll Thanks, address Judah. Matt. is that. Yes. This

that about sales as the deep So experience really I'm actually yet as bring. our excited far they goes, of set backgrounds, force diverse

and therapeutics medical device We diagnostics. backgrounds, classic have pharmaceutical visual folks prescription, well have as as that

to them unique So Akili. each of something brings

then of I collect reps. to learn plan we use your abroad we target targets or XX as to as across And practices, practice next starting XX to the to first those and this opportunity are expand on best just sales geographic using do focused XX We're roughly comments can on U.S. indicated, we wave expect over this onboarded going territories. best with those to high-priority the quickly, We've months. far As really

In the terms of marketing these supported on an reps are support, integrated caregivers. sales well in mentioned, plan as field both as as today I HCPs marketing by focusing

through like So social of our caregiver engagement channels media is a critical strategy. part

have continue programs, effectiveness in as do the marketing We that adjust And done forward. the of year. all learn. monitor going to that past We'll with we'll mix we our and the

Judah Frommer

any helpful. And extended -- you then change. Okay. up give, do or price the anything then $XX would on see out-of-pocket following little can time? time as you an coming script? dynamics in there they being gap just the That's Great. give other insights you change a us what of bit of pricing? be on And refills? anecdotal, for it you introductory? How if can around it's after refill drove as Is in period background a even give us soon on first else Are anything the pricing? kind sticking you relatively of just see see Do on this helpful. Can you Do it

Matthew Franklin

Yes, absolutely.

change. So first, the on price

today. our from providers, stakeholders, the So from price feedback prescription caregivers, payers, prescription and the direct aligns XX-day XX-day practices their the with from simply really change that better XX-day move based from to were on

to So on to go really that. trying

keep far items, at $XX, monitoring market, to changes one. new critical long the As is medicine, getting of and category as as we the evaluating how the constantly a pricing constantly we're will price feedback

don't information XX-day that though price to have for share at time. list this So consistent stay $XXX is we're should to do go prescription. time. our important at additional evaluating We note a where any over It that price

Judah Frommer

And anything give there you also can refill? us it. Got Okay. is on

Matthew Franklin

Yes.

monitor But refill information prescription refills, with of have of the early We'll continue for XXXX. year. and on refills. and is launch a changes course days in We'll the our Refills share data past over focus growth, are Sorry, having to right the refills the to more us. the driving business number made critical awareness, so on prescriber growth. now on

Operator

Our next Rakhit from question of the Capital. coming LifeSci Rahul line with is

Rahul Rakhit

new lot lot I some salespeople, little bit guys hear facilitated through are your website? telemedicine a you whether that are interested that also being the -- to you're visits by know patients traffic you new decent but coming through of about through driving end? seeing coming a from your our scripts Are a seeing pretty

Matthew Franklin

One telemedicine there Yes. see have for Thanks the we our force. a been by has X One that consistent territories, in. ways Telemedicine and Matt. in we It's is come others sales prescriptions Again, demands initiated sales question. yet sort yes, organic those are force. is contributor direct the from of don't for us.

to we that consistent It's details out important channel broken yet. haven't channels. But forward. haven't been on We different performer. us going the It's percentage offer of those for by prescriptions a shared

Rahul Rakhit

a and Yes script kind more any to Are than providers of writing helpful. docs have could for it then just was that. with on think from know more be I these you appreciate me commentary I think offering EndeavorRx volumes wondering base just it's if would comfortable I seeing and patients? I get the the who I scripts little of providers. still about providers early, about you pretty been prescribing bit existing but a thinking quarter. are tell how new those growing

Matthew Franklin

force for sales field. Yes. in with an haven't Again, we time the extensive question. early Thanks had days, the

growth expand out again, growth or and quarter-over-quarter sales prescription time, plans going provided expected or that haven't year-over-year this with at details said, forecast our broken provided now and haven't growth over With we geographically or we So growth do force around point. guidance yet additional anticipate we field forecast. to in forward. continued But the

Rahul Rakhit

Medicare I finalized been the the I how know but you yet, Got if seen of the about changed? benefit thinking guess, in. how then on right. based legislation guys the haven't election results Yes, are this squeeze it. point, All likelihood that category has changes this from for one And could passing to the we've I more up

Walter Martucci

question. Great Thanks, Yes. Rahul.

there's for still that. definitely therapeutic a I support I the prescription very behind of like create think to We're think -- piece much categories. that we that digital category FDA-approved other therapeutics, legislation a just

I aisles the sphere. touching that the options think -- in this lack is that there's both this party sides. is my not constituents, This perspective is touching lines. meaning constituents the is across of good crosses something treatment political really is on Frankly,

And with our we and to stay to here. continue the continue so push legislation course

Operator

like allotted Martucci to today's comments. That is any to now closing for for the back I would call. Eddie all have the time we hand call

Walter Martucci

and In we pleased ahead of EndeavorRx you. to XX. so with opportunity our Thank are have we're we believe see. us. Slide the I'm Thanks signals the and some early excited that There capital the to growth early closing, it. the We've on a the starting highlights captured bit much, short, we're talked In fund progress. about success of about do that team to everybody.

prepared business and as now, Right hopefully our in our model as hone answers, we from for and be comments our on can the business as to profitable possible focused scale you foundation adapting tell to as markets the the future. our efficient we're in set quickly and growth

see and That's we'll doing. to we're quarter-over-quarter So that's be what updating we what on, hope progress.

we that progress. and cognitive attention. look I well. you as all our issues, continuing more their on your patients lives, update we Thank the to all hopefully, in see improve reflected as with forward transparently to help business for you And more

for all attention. you the So thank

Operator

This today's We participation. does your teleconference. conclude appreciate

your You rest of the Enjoy may day. at your time. disconnect this lines

Akili (AKLI) 10 Nov 222022 Q3 Earnings call transcript